Literature DB >> 27380427

LONG-TERM FOLLOW-UP OF PATIENTS WITH RETINITIS PIGMENTOSA TYPE 12 CAUSED BY CRB1 MUTATIONS: A Severe Phenotype With Considerable Interindividual Variability.

Inge B Mathijssen1, Ralph J Florijn, L Ingeborgh van den Born, Renate C Zekveld-Vroon, Jacoline B Ten Brink, Astrid S Plomp, Frank Baas, Hanne Meijers-Heijboer, Arthur A B Bergen, Mary J van Schooneveld.   

Abstract

PURPOSE: To examine the long-term clinical course and variability in a large pedigree segregating CRB1 type autosomal recessive retinitis pigmentosa.
METHODS: An observational case study of 30 patients with CRB1 type autosomal recessive retinitis pigmentosa, homozygous for the CRB1 c.3122T > C; p.(Met1041Thr) mutation from a Dutch genetically isolated population in which the CRB1 gene was originally identified. The authors evaluated medical records, analyzed a questionnaire, and performed a comprehensive ophthalmic examination, including optical coherence tomography.
RESULTS: Mean follow-up was 19 years (range 0-45 years, SD 15 years). With aging, patients showed progressive visual decline, deterioration of visual fields, increasing narrowing of the anterior chamber, increased prevalence of cataract, and an increase in the amount of intraretinal pigmentations. Fifty percent of patients had a visual acuity of ≤0.3 at Age 18 and of ≤0.1 at Age 35. Electroretinogram responses were severely reduced or absent already at a young age and optical coherence tomography showed increased retinal thickness with often cystoid maculopathy at young age, and thinning of the retina and disorientation of the photoreceptor layer in the late stages. The clinical course showed considerable interindividual variability, but intraindividual similarity between both eyes was the rule.
CONCLUSION: The wide and variable clinical spectrum in patients with the same CRB1 mutation supports the hypothesis that the CRB1 type autosomal recessive retinitis pigmentosa-phenotype is modulated by other factors. The clinical variability will make it harder to evaluate the effect of (upcoming) therapies for retinitis pigmentosa, although because of the intraindividual similarity between both eyes, the contralateral eye can be used as an excellent internal control.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27380427     DOI: 10.1097/IAE.0000000000001127

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  13 in total

1.  A novel CRX variant (p.R98X) is identified in a Chinese family of Retinitis pigmentosa with atypical and mild manifestations.

Authors:  Yingchuan Zhu; Hao Tan; Jiarong Zeng; Dachang Tao; Yongxin Ma; Yunqiang Liu
Journal:  Genes Genomics       Date:  2018-11-20       Impact factor: 1.839

2.  Longitudinal Clinical Follow-up and Genetic Spectrum of Patients With Rod-Cone Dystrophy Associated With Mutations in PDE6A and PDE6B.

Authors:  Samer Khateb; Marco Nassisi; Kinga M Bujakowska; Cécile Méjécase; Christel Condroyer; Aline Antonio; Marine Foussard; Vanessa Démontant; Saddek Mohand-Saïd; José-Alain Sahel; Christina Zeitz; Isabelle Audo
Journal:  JAMA Ophthalmol       Date:  2019-06-01       Impact factor: 7.389

3.  Defining inclusion criteria and endpoints for clinical trials: a prospective cross-sectional study in CRB1-associated retinal dystrophies.

Authors:  Mays Talib; Mary J van Schooneveld; Jan Wijnholds; Maria M van Genderen; Nicoline E Schalij-Delfos; Herman E Talsma; Ralph J Florijn; Jacoline B Ten Brink; Frans P M Cremers; Alberta A H J Thiadens; L Ingeborgh van den Born; Carel B Hoyng; Magda A Meester-Smoor; Arthur A Bergen; Camiel J F Boon
Journal:  Acta Ophthalmol       Date:  2021-02-02       Impact factor: 3.761

4.  Ocular Biometry in Primary Angle-Closure Glaucoma Associated with Retinitis Pigmentosa.

Authors:  Jiangang Xu; Zhikun Ouyang; Yangfan Yang; Xiaoyu Cai; Zhonghao Wang; Mingkai Lin; Xiulan Zhang; Xing Liu; Minbin Yu
Journal:  J Ophthalmol       Date:  2017-12-31       Impact factor: 1.909

5.  The correlation between CRB1 variants and the clinical severity of Brazilian patients with different inherited retinal dystrophy phenotypes.

Authors:  Fabiana Louise Motta; Mariana Vallim Salles; Karita Antunes Costa; Rafael Filippelli-Silva; Renan Paulo Martin; Juliana Maria Ferraz Sallum
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

6.  With expanded carrier screening, founder populations run the risk of being overlooked.

Authors:  Inge B Mathijssen; Merel C van Maarle; Iris I M Kleiss; Egbert J W Redeker; Leo P Ten Kate; Lidewij Henneman; Hanne Meijers-Heijboer
Journal:  J Community Genet       Date:  2017-05-29

7.  Long-Term Follow-Up of Retinal Degenerations Associated With LRAT Mutations and Their Comparability to Phenotypes Associated With RPE65 Mutations.

Authors:  Mays Talib; Mary J van Schooneveld; Roos J G van Duuren; Caroline Van Cauwenbergh; Jacoline B Ten Brink; Elfride De Baere; Ralph J Florijn; Nicoline E Schalij-Delfos; Bart P Leroy; Arthur A Bergen; Camiel J F Boon
Journal:  Transl Vis Sci Technol       Date:  2019-08-19       Impact factor: 3.283

8.  Chromatic Full-Field Stimulus Threshold and Pupillography as Functional Markers for Late-Stage, Early-Onset Retinitis Pigmentosa Caused by CRB1 Mutations.

Authors:  Krunoslav T Stingl; Laura Kuehlewein; Nicole Weisschuh; Saskia Biskup; Frans P M Cremers; M Imran Khan; Carina Kelbsch; Tobias Peters; Marius Ueffing; Barbara Wilhelm; Eberhart Zrenner; Katarina Stingl
Journal:  Transl Vis Sci Technol       Date:  2019-12-20       Impact factor: 3.283

9.  Retinal detachment in retinitis pigmentosa.

Authors:  Weng Onn Chan; Nicholas Brennan; Andrew R Webster; Michel Michaelides; Mahiul M K Muqit
Journal:  BMJ Open Ophthalmol       Date:  2020-07-09

Review 10.  Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations.

Authors:  Mays Talib; Camiel J F Boon
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.